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Summary
 
T1/ST2, an orphan receptor with homology with the interleukin (IL)-1 receptor family, is ex-
pressed constitutively and stably on the surface of T helper type 2 (Th2) cells, but not on Th1
cells. T1/ST2 is also expressed on mast cells, which are critical for Th2-mediated effector re-
sponses. To evaluate whether T1/ST2 is required for Th2 responses and mast cell function, we
have generated T1/ST2-deficient (T1/ST2
 
2
 
/
 
2
 
) mice and examined the roles of T1/ST2. Naive
CD4
 
1
 
 T cells isolated from T1/ST2
 
2
 
/
 
2
 
 mice developed to Th2 cells in response to IL-4 in
vitro. T1/ST2
 
2
 
/
 
2
 
 mice showed normal Th2 responses after infection with the helminthic para-
site 
 
Nippostrongylus brasiliensis
 
 as well as in the mouse model of allergen-induced airway inflam-
mation. In addition, differentiation and function of bone marrow–derived cultured mast cells
were unaffected. These findings demonstrate that T1/ST2 does not play an essential role in de-
velopment and function of Th2 cells and mast cells.
Key words: gene targeting • interleukin 1 receptor family • mast cell • asthma • T helper cells 
types 1 and 2
 
T
 
he orphan receptor T1/ST2 belongs to the IL-1R fam-
ily. The T1/ST2 gene was originally identified as a late
response gene that was induced by either serum or overex-
pression of v-
 
mos
 
 and Ha-
 
ras
 
 oncogenes in murine fibroblasts
(1–3). Alternative 3
 
9
 
 processing of the primary transcript
generates two messengers of 2.7 and 5 kb long. The short
mRNA encodes a 38.5-kD peptide with similarity to the
extracellular portion of the IL-1Rs (4), and is secreted from
the cell as a heavily glycosylated protein of 50–60 kD. The
short mRNA is found in embryonic tissues and mammary
tumors, and is induced in fibroblasts upon stimulation with
proliferation-inducing agents such as serum, platelet-derived
growth factor, fibroblast growth factor, 12-
 
O
 
-tetradecanoyl-
phorbol-13-acetate, and lysophosphatidic acid (2, 5, 6). On
the other hand, the long mRNA encodes a single transmem-
brane-spanning protein with significant homology to the
type 1 IL-1R. Expression of the long mRNA was restricted
to hematopoietic organs and the lung (5, 7). The gene for
ST2 was mapped to mouse chromosome 1 closely linked to
the 
 
il-1r
 
 locus containing both type I and type II receptor
genes, in support of their common ancestry (8). Despite
their similarity to the IL-1R, the T1/ST2 proteins do not
bind either IL-1
 
a
 
 or IL-1
 
b
 
 (9, 10). Two different groups
have reported the identification of putative T1/ST2 ligands,
but it is still unclear whether these proteins indeed repre-
sent the physiological T1/ST2 ligands (9, 11).
Th cells are categorized into two subsets, Th1 and Th2
cells, based on their cytokine production. Th1 cells secrete
IL-2 and IFN-
 
g
 
, which promote mainly cellular immunity.
Th2 cells produce IL-4, IL-5, IL-10, and IL-13, and pro-
mote mainly humoral immunity (12, 13). The Th1 to Th2
balance determines the outcome of a wide variety of im-
mune responses involving infectious, autoimmune, and al-
lergic diseases. Acquired resistance against intracellular bac-
teria is associated with the Th1 response, whereas resistance
against helminths is achieved by the Th2 response (14).
Autoimmune diseases such as multiple sclerosis and Crohn’s
disease are associated with an abnormally strong Th1 response,
whereas allergic diseases seem to involve an abnormally
strong Th2 response (15–18). Both Th1 and Th2 cells are
derived from a common precursor cell named naive Th
cells: IL-12 stimulates the differentiation of naive Th to Th1
cells (19), whereas IL-4 regulates Th2 differentiation (20,
21). These cytokines are produced in the early phase of in- 
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fection: IL-12 derives from infected macrophages (22), and
IL-4 from basophils, mast cells, and CD4
 
1
 
NK1.1
 
1
 
 T cells
(23–25).
Recently it has been demonstrated that T1/ST2 is pref-
erentially expressed on murine Th2 cells and is important for
Th2 effector functions. Using differential display PCR com-
paring a panel of Th1 and Th2 clones, Xu et al. (26) and
Löhning et al. (27) independently identified 
 
T1/ST2
 
 as a gene
expressed on Th2 but not Th1 cells. T1/ST2 is constitu-
tively and stably expressed on the surface of murine Th2
cells. Furthermore, Th1/Th2 cytokine coexpression is ob-
served in the T1/ST2-negative population but not in the
T1/ST2-positive population, indicating that surface expres-
sion of T1/ST2 is an advanced commitment to the Th2
phenotype. In vivo administration of anti-T1/ST2 Ab en-
hanced Th1 responses by increasing IFN-
 
g
 
 production and
decreasing IL-4 and IL-5 synthesis, and thereby induced re-
sistance to 
 
Leishmania major
 
 infection in BALB/c mice and
exacerbated collagen-induced arthritis in DBA/1 mice. In
addition, pretreatment with anti-T1/ST2 Ab or T1/ST2
fusion protein abrogated both the accumulation of eosino-
phils in the airways and the secretion of Th2 cytokines in a
murine model of Th2-dependent allergic airway inflamma-
tion. Mast cells are critical effectors in Th2 cell–dependent im-
mune responses and in the pathogenesis of Th2 cell–depen-
dent disorders. Mast cells are also found to express T1/ST2 at
high levels (28, 29).
In this study, we have generated mice deficient in the T1/
ST2 gene, and using the mutant mice we examined the roles
of T1/ST2 in helminth infection and a mouse model of
asthma, as well as in mast cell differentiation and function.
 
Materials and Methods
 
Reagents.
 
Recombinant murine IL-12 was provided by Haya-
shibara Biochemical Laboratories, Inc. (Okayama, Japan). FITC-
conjugated anti–mouse T1/ST2 Ab (clone DJ8) was purchased
from Morwell Diagnostics GmbH. Levels of IL-4, IL-5, IL-10,
and IFN-
 
g
 
 were determined
 
 
 
by ELISA kit (Genzyme).
 
Cell Culture.
 
Lymphoid cell growth medium consisted of RPMI
1640 medium (Life Technologies) supplemented with 10% (vol/
vol) fetal bovine serum, 100 
 
m
 
M 2-ME, 5 U/ml penicillin, and
50 
 
m
 
g/ml streptomycin. Bone marrow cell culture medium con-
sisted of 
 
a
 
MEM (Life Technologies) supplemented with 10%
(vol/vol) fetal bovine serum, 5 U/ml penicillin, and 50 
 
m
 
g/ml
streptomycin.
 
Generation of T1/ST2-deficient Mice.
 
The T1/ST2 locus on the
mouse genome has been submitted to the EMBL/GenBank/
DDBJ database (available under accession no. X60184). A target-
ing vector was designed to replace a 1,280-bp genomic fragment
encoding amino acids 1–96 of the mature T1/ST2 with neomy-
cin resistance gene (
 
neo
 
) from pMC1-neo (Stratagene). The target-
ing vector was flanked by the 5.8-kbp fragment at the 3
 
9
 
 end and
the 1.0-kbp fragment at the 5
 
9
 
 end. A herpes simplex virus–thymi-
dine kinase gene (HSV-tk) was inserted into the 3
 
9
 
 end of the
vector. The targeting vector was linearized with SalI and electro-
porated into E14.1 embryonic stem (ES) cells. The clones resis-
tant to G418 and ganciclovir were screened by PCR and confirmed
by Southern blot analysis with the probe shown in Fig. 1 A for
homologous recombination. An external primer (5
 
9
 
-AGGTG-
GATTATGACGTTGTGCTCATGG-3
 
9
 
) specific for the T1/ST2
gene upstream of the targeting construct and a neo primer
(5
 
9
 
-ATCGCCTTCTATCGCCTTCTTGACGAG-3
 
9
 
) specific for
 
neo
 
 were used in the PCR screening. Generation of chimeric mice
and mutant mice was essentially as described previously (30).
 
In Vitro Induction of Th1/Th2 Cell Differentiation.
 
Splenocytes
were incubated with biotinylated anti–I-A
 
b
 
 Ab (clone 25-9-17;
PharMingen), biotinylated anti-CD8 Ab (clone 53-6.7; Phar-
Mingen), biotinylated anti–pan-NK cell Ab (clone DX5; Phar-
Mingen), biotinylated anti-CD45R Ab (clone RA3-6B2; PharMin-
gen), and streptavidin microbeads (MACS; Miltenyi Biotec)
followed by magnetic field separation to remove MHC class II,
CD8, and B220-expressing cells and NK cells. Cell purity was
analyzed by flow cytometry using FITC-conjugated anti-CD3
Ab (clone 145-2C11; PharMingen) and PE-conjugated anti-CD4
Ab (clone L3T4; PharMingen). Purified cells were cultured on
10 
 
m
 
g/ml anti-CD3 Ab–coated plates (clone 145-2C11; Phar-
Mingen) in the presence of exogenous cytokines and anticyto-
kine Ab as indicated. Th2 differentiation was promoted in the
presence of 1,000 U/ml IL-4 (PharMingen) and 10 
 
m
 
g/ml anti–
IFN-
 
g
 
 Ab (clone XMG1.2; Endogen), whereas Th1 differentia-
tion was promoted in the presence of 2 ng/ml IL-12. After the
5-d culture, cells were harvested and washed with HBSS. Cells
(10
 
6
 
/ml) were stimulated on an anti-CD3 Ab–coated 96-well
plate for 24 h. Supernatants were analyzed by cytokine ELISA.
After 8 d of culture, cells were also analyzed for intracellular
cytokines. Staining was performed by Cytofix/CytoPerm Plus kit
(PharMingen). The following Abs were used: Cy-Chrome–con-
jugated anti-CD4 Ab (clone H129.19; PharMingen), PE-conju-
gated anti–IL-4 Ab (clone BVD4-1D11; PharMingen), and FITC-
conjugated anti–IFN-
 
g
 
 Ab (clone XMG1.2; PharMingen). Samples
were analyzed by three-color flow cytometry, and gates were set
on CD4
 
1
 
 lymphocytes.
 
Nippostrongylus Infection.
 
800 third-stage 
 
Nippostrongylus brasil-
iensis
 
 larvae were injected subcutaneously into 10-wk-old T1/
ST2
 
2
 
/
 
2
 
 and wild-type control mice. Mice were killed 8 d after
infection, and CD4
 
1
 
 T cells were enriched from the spleen by
positive selection on LS
 
1
 
 columns (MACS), according to the
manufacturer’s instructions (Miltenyi Biotec). CD4
 
1
 
 T cells were
cultured at 10
 
6
 
/ml in 96-well plates coated with 10 
 
m
 
g/ml anti-
CD3 Ab for 24 h. Supernatants were analyzed by cytokine
ELISA. In a separate experiment, serum Ig levels were measured
by ELISA.
 
Bone Marrow–derived Mast Cell Preparation and Stimulation.
 
Bone marrow was aseptically flushed from femora of 8-wk-old
mice. The cells were cultured at 10
 
6
 
/ml in bone marrow cell
culture medium supplemented with 10% (vol/vol) PWM-stimu-
lated spleen cell conditioned medium (31) for 3 wk. The bone
marrow cultures were enriched for mast cells by repetitively
transferring the suspension cell fraction into fresh culture flasks.
After 3 wk of culture, culture medium was changed to bone mar-
row cell culture medium containing 10 ng/ml recombinant mouse
IL-3 (Genzyme/Techne). After 1 wk of culture, mast cells were
analyzed for T1/ST2 expression by incubating with IgE,
 
k
 
 (clone
IgE-3; PharMingen), PE-conjugated anti–c-Kit (clone 3C1; Im-
munotech), and 0.8 
 
m
 
g/ml FITC-conjugated anti-T1/ST2 Ab,
followed by biotinylated anti–mouse IgE (clone R35-92; Phar-
Mingen) and Cy-Chrome–conjugated streptavidin (PharMingen).
After washing, cells were resuspended at 10
 
6
 
/ml and stimu-
lated for 24 h with the polyclonal activator PMA at 50 ng/ml and
1 
 
m
 
M ionomycin. Supernatants were analyzed by cytokine ELISA.
IgE cross-linking was performed by first incubating the cells for
30 min at 37
 
8
 
C in the presence of 3 
 
m
 
g/ml of monoclonal mouse 
1543
 
Hoshino et al. Brief Definitive Report
IgE anti-dinitrophenyl group (DNP) (clone SPE-7; Sigma Chemi-
cal Co.). The mast cells were washed three times and then incu-
bated with 10 ng/ml DNP
 
30–40
 
 HSA (Sigma Chemical Co.) for
30 min at 37
 
8
 
C. After the treatment with antigens, supernatants
were measured for histamine concentration by RIA (SRL, Inc.).
 
Sensitization Procedure and Allergen Exposure.
 
Immunization and
exposure of mice were carried out according to the method of
Foster et al. (32). In brief, 8- or 10-wk-old mice were sensitized
by intraperitoneal injection with 50 
 
m
 
g OVA/1 mg aluminum
hydroxide in 0.9% saline on days 0 and 12. Nonsensitized mice
received 1 mg of aluminum hydroxide in 0.9% saline. On day 24,
mice were placed individually in a chamber and inhaled aero-
solized OVA (10 mg/ml) in 0.9% saline (sensitized, OVA-chal-
lenged group) for 30 min three times at 1-h intervals, and then
every second day thereafter, for 8 d. Nonsensitized mice received
saline only (nonsensitized, nonchallenged group). The aerosols
were generated by ultrasonic nebulization. 24 h after the last
aeroallergen challenge, the mice were anesthetized by intraperi-
toneal injection of pentobarbital (80 mg/kg body wt) and used
for the following experiments. The blood was collected, and se-
rum Ig levels were measured by ELISA.
 
Bronchoalveolar Lavage.
 
The trachea was cannulated, and the
airway lumina were washed twice with 0.5 ml of PBS (Ca
 
2
 
1
 
,
Mg
 
2
 
1
 
 free) supplemented with 50 
 
m
 
M EDTA and 0.1% BSA.
The bronchoalveolar lavage (BAL) fluid was immediately centri-
fuged (10 min at 4
 
8
 
C, 700 
 
g
 
). The BAL cells were resuspended in
0.2 ml of rat serum and counted using a hemocytometer. For dif-
ferential cell counts, 2–4 
 
3
 
 10
 
3
 
 cells were spun onto glass slides,
air dried, fixed with ethanol, and stained with Giemsa solution.
The numbers of eosinophils, neutrophils, lymphocytes, and mac-
rophages in 200 cells were counted based on morphology and
staining characteristics.
 
ELISA for Measurement of Serum Ig Level.
 
Serum IgG1 level was
measured as described previously (33), except that the following
reagents were used: goat anti–mouse IgG1, mouse IgG1, biotiny-
lated goat anti–mouse IgG1, and streptavidin-conjugated alkaline
phosphatase (Southern Biotechnology Associates). Serum IgE level
was measured according to protocol supplied by PharMingen.
 
Results and Discussion
 
Generation of T1/ST2-deficient Mice.
 
The mouse T1/ST2
gene was disrupted by homologous recombination in E14.1
ES cells. A targeting vector was designed to delete the first
and second ATG codons of T1/ST2 with the neomycin
resistance gene (Fig. 1 A). 2 out of 733 clones screened
were positive for homologous recombination. Two targeted
ES clones were microinjected into C57BL/6 blastocysts,
and successfully transmitted the disrupted T1/ST2 gene
through the germline (Fig. 1 B). T1/ST2
 
2
 
/
 
2 
 
mice were
born at the expected Mendelian ratios (
 
1
 
/
 
1
 
: 
 
1
 
/
 
2
 
: 
 
2
 
/
 
2
 
 
 
5
 
55: 96: 49). The mice grew healthy and showed no obvi-
ous abnormalities until 20 wk old. Homozygous mutants of
both sexes were fertile, and there was no significant differ-
ence in the birth rate between T1/ST2
 
2
 
/
 
2
 
 and wild-type
mice. Thus, T1/ST2 was not required for mouse develop-
ment or fertility. Reverse transcription (RT)-PCR analysis
using total RNA from bone marrow cells of T1/ST2
 
2
 
/
 
2
 
mice confirmed the absence of expression of T1/ST2
mRNA (Fig. 1 C). T1/ST2 has been shown to be abun-
dantly expressed on the cell surface of mast cells and Th2
cells (26–29). When bone marrow cells were cultured in the
presence of IL-3, these cells differentiated into mast cells
expressing both high-affinity IgE receptor, Fc
 
e
 
RI, and c-Kit
receptor. Analysis by two-color dot plot revealed that
Figure 1. Targeted disruption of the mouse T1/ST2 gene. (A) Targeting vector and restriction map of the T1/ST2 locus. The restriction map of the
wild-type allele, targeting vector, and mutated allele is shown. Open and filled boxes denote the noncoding and coding exons, respectively. The orienta-
tion of the neomycin resistance gene (neo) and the herpes simplex virus–thymidine kinase gene (HSV-TK) are indicated by the arrow. E, EcoRI; B,
BamHI. (B) Southern blot analysis of offspring from the heterozygote intercrosses. Genomic DNA was extracted from mouse tails, digested with BamHI,
electrophoresed, and hybridized with the probe as shown in A. The approximate size of the wild-type band is 6.8 kbp, and the mutated band is 2.2 kbp.
1/1, wild-type; 1/2, heterozygous mutant; 2/2, homozygous mutant. (C) RT-PCR analysis of T1/ST2 mRNA. Total RNA was isolated from the
bone marrow cells. PCR analysis was performed using specific primers for T1/ST2 or for b-actin (reference 38). (D) Expression of T1/ST2 on BMC-
MCs. BMCMCs were triple stained with FITC–anti-T1/ST2 Ab, PE–anti–c-Kit Ab, IgE/biotin–anti-IgE Ab/Streptavidin–Cy-Chrome. T1/ST2 ex-
pression was analyzed in histogram mode by gating on the IgE1c-Kit1 double positive population which was .99% of the cells analyzed.1544 Gene Targeting of T1/ST2
.99% of the cells were IgE1c-Kit1 double positive (data not
shown). In wild-type mice, these bone marrow–derived
mast cells expressed T1/ST2 on their cell surface (Fig. 1 D).
In contrast, T1/ST2 was not expressed on T1/ST22/2 mast
cells. When splenic CD41 T cells were skewed for Th2 cell
differentiation, several cells expressed T1/ST2 on their cell
surface (data not shown). However, Th2-skewed CD41 T
cells from T1/ST22/2 mice did not express T1/ST2 at all.
Thus, targeted disruption of the T1/ST2 gene resulted in
no expression of T1/ST2 protein in mice. FACS® analysis
of the expression of CD3, B220, CD4, CD8, I-Ab, and
IgM in thymocytes and splenocytes showed that lympho-
cyte composition was not altered in 6-wk-old T1/ST22/2
mice compared with wild-type mice of the same age (data
not shown).
Normal Th2-mediated Functions in T1/ST22/2 Mice. It has
recently been shown that treatment of mice with anti-T1/
ST2 Ab resulted in decreased Th2 cell–mediated functions,
indicating that T1/ST2 might be functionally associated
with Th2 cells (26, 27). Therefore, we analyzed in vitro
and in vivo Th2 responses of T1/ST22/2 mice. First, we
explored in vitro differentiation assays to assess the effect of
T1/ST2 deficiency on cytokine production from Th cells.
CD41 T cells were cultured for 5 d in the presence of IL-12
or IL-4 plus anti–IFN-g Ab to develop into Th1 or Th2
cells, respectively. Th1-developing cells from both wild-type
and T1/ST22/2 mice produced almost equal amounts of
IFN-g (Fig. 2 A). Th2-developing cells from wild-type
mice produced increased levels of Th2 cytokines such as
IL-4, IL-5, and IL-10. The cells from T1/ST22/2 mice also
produced the equivalent levels of Th2 cytokines. Th cells
from wild-type mice developed into IL-4 producers in re-
sponse to IL-4 or into IFN-g producers in response to IL-12
(Fig. 2 B). The cells from T1/ST22/2 mice developed into
IL-4 or IFN-g producer cells as did the cells from wild-type
mice. These results indicate that IL-4–induced in vitro Th2
cell differentiation was not affected in T1/ST22/2 mice.
Next, we examined in vivo Th2 response by infecting
with the intestinal parasitic nematode N. brasiliensis. CD41
splenic T cells were prepared 8 d after infection and stimu-
lated with immobilized anti-CD3 Ab for 24 h. The super-
natants were assayed for cytokine production by ELISA. Both
wild-type and T1/ST22/2 CD41 T cells produced the same
amounts of IL-4 (Fig. 3 A). IFN-g production from both
CD41 T cells was almost the same. IL-4 is shown to be re-
quired for Ig class switching of B cells to IgE and IgG1 pro-
ducers (20, 21, 34–36). Therefore, we measured serum Ig
levels before and after N. brasiliensis infection. Total serum
IgE and IgG1 levels after infection were almost equivalent
in both wild-type and T1/ST22/2 mice (Fig. 3 B). These
data indicate that T1/ST2 is not functionally involved in
Th2 response in vivo.
Normal Functions of Mast Cells in T1/ST22/2 Mice. T1/ST2
has been shown to be expressed on bone marrow–derived
cultured mast cells (BMCMCs) and peritoneal mast cells
and to be regarded as a cell surface marker for the mast cell
lineage (28, 29). Mast cells have been shown to secrete IL-4
and histamine when stimulated. We analyzed production
of these mediators from BMCMCs. Both wild-type and
T1/ST22/2 BMCMCs secreted almost the same levels of
IL-4 upon stimulation with PMA and ionomycin (Fig. 4 A).
Further, both wild-type and T1/ST22/2 cells released al-
most equal levels of histamine in response to IgE and Ag
(Fig. 4 B). Mast cells were classified into two subtypes: the
connective tissue–type mast cell, which is found in the
skin, musculature, perivascular tissues, and peritoneal cavity,
and the mucosal mast cell, which is widely distributed in
mucosal tissues of the respiratory tract and the intestinal
lamina propria (37). The number of connective tissue–type
mast cells in the back skin of T1/ST22/2 mice was almost
the same as that of wild-type mice. The number of mucosal
mast cells in the lamina propria of the stomach was also
equivalent between T1/ST22/2 and wild-type mice, indicat-
ing that mast cell development is not affected in T1/ST22/2
mice (data not shown). Thus, our data suggest that T1/ST2
expression does not contribute to development and func-
tion of mast cells.
Development of Allergen-induced Airway Inflammation in
T1/ST22/2 Mice. It has been shown that Th2-mediated
eosinophilic lung inflammation of airways is attenuated by
pretreatment with anti-T1/ST2 mAb (27). Therefore, we
examined whether T1/ST2 deficiency influences inflam-
Figure 2. Cytokine production after in
vitro Th cell differentiation. (A) CD41 T
cells purified from spleen from wild-type and
T1/ST22/2 mice were stimulated under Th1
or Th2 culture conditions for 5 d, washed,
and restimulated on anti-CD3 Ab–coated
plates for 24 h. Supernatants were analyzed
for production of IL-4, IL-5, IL-10 and
IFN-g by ELISA. The experiment shown is
representative of three independent experi-
ments. (B) FACS® analysis of intracellular
cytokine. CD41 T cells were cultured under
Th1 or Th2 condition for 8 d, then stimulated
for 4 h with PMA/ionomycin, fixed, and
stained for CD4, IL-4, and IFN-g. For anal-
ysis, gate was set on CD41 lymphocytes. The
frequency of cytokine-producing CD41 cells
is indicated in the quadrants as a percent.1545 Hoshino et al. Brief Definitive Report
matory responses in the murine model of Th2-dependent
allergic airway inflammation. Wild-type and T1/ST22/2
mice immunized with OVA were exposed to an aerosol of
OVA. 24 h after OVA challenge, mice were bled, and se-
rum concentrations of IgE and IgG1 were measured by
ELISA. Serum concentrations of IgE and IgG1 were equally
increased after OVA treatment in both wild-type and T1/
ST22/2 mice (Fig. 5 A). We also analyzed the cells in BAL
fluid 24 h after the exposure to OVA aerosol. The total cell
number of BAL cells was dramatically increased after OVA
exposure in both wild-type and T1/ST22/2 mice (Fig. 5 B).
Furthermore, a dramatic increase in eosinophils was observed
in both wild-type and T1/ST22/2 mice. Histological analysis
of lung taken from both wild-type and T1/ST22/2 mice
exposed to OVA displayed severe widespread inflammatory
infiltration (data not shown). Thus, T1/ST22/2 mice exhib-
ited normal eosinophilic response in the mouse model of
allergic airway inflammation.
In this study, we generated T1/ST22/2 mice and ana-
lyzed their phenotype. T1/ST2 has been shown to be ex-
pressed on the cell surface of Th2 cells, but not Th1 cells.
Furthermore, administration of anti-T1/ST2 Ab resulted in
reduced Th2-mediated functions in mice (26, 27). Thus,
T1/ST2 has been implicated in Th2-mediated functions.
However, T1/ST22/2 mice displayed almost normal Th2
responses in both nematode infection and allergic airway
inflammation. These results clearly demonstrate that T1/
ST2 is not essential to Th2 cell functions. Since it has been
shown that treatment of Th2 cells with anti-T1/ST2 Ab
enhances complement-mediated lysis in vitro (26), the re-
duced Th2-mediated functions observed in the studies with
anti-T1/ST2 Ab administration might be a result of com-
plement-mediated elimination of the T1/ST2-positive cell
population. In addition to Th2 cells, mast cells express high
levels of T1/ST2. However, development and activity of
mast cells were unaffected in T1/ST22/2 mice. Thus, our
knockout study reveals that T1/ST2 does not play a critical
role in development and function of Th2 cells and mast cells,
although we cannot rule out the possibility that T1/ST2 may
play some role in Th2 response. Alternatively, T1/ST2 may
have an unknown function in these or other cell popula-
tions. At present, a ligand for T1/ST2 has not been identi-
fied. The identification of the ligand will reveal a novel
function of T1/ST2 as well as its role in Th2 response.
Figure 3. Cytokine production from splenic T cells and serum Ig levels
in response to parasite infection. (A) Splenic CD41 T cells were prepared
from uninfected animals (d0) or animals 8 d after infection (d8) with N.
brasiliensis. Cells were stimulated with immobilized anti-CD3 Ab for 24 h.
Supernatants were analyzed by ELISA. Data are representative of three
experiments consisting of cohorts of two mice at each time point. (B) T1/
ST22/2 mice (eight mice) and wild-type (six mice) were infected with N.
brasiliensis. Serum IgE and IgG1 levels were measured at days 0, 8, 14, and
21 after infection. Serum samples were assayed by ELISA. Data are pre-
sented as mean 6 SEM. N.D., not detectable.
Figure 4. Mast cell analysis. (A) BMCMCs from T1/ST22/2 and wild-
type mice were stimulated with PMA and ionomycin for 24 h. Superna-
tants were analyzed by ELISA. (B) Histamine release from BMCMCs
stimulated with IgE and specific antigen. The data shown are representa-
tive of the three experiments. Data are presented as mean 6 SEM. N.D.,
not detectable.
Figure 5. Analysis of Th2 effector function of T1/ST22/2 mice on a
mouse model of asthma. (A) Changes in serum concentrations of IgE and
IgG1 induced by OVA treatment. Data are presented as mean 6 SEM for
six mice. (B) BAL cell number and cellular distribution of BAL fluid.
BAL fluid was obtained from T1/ST22/2 and wild-type mice after treat-
ment with or without OVA. The columns represent the absolute num-
bers of total BAL cells, eosinophils, neutrophils, lymphocytes and mac-
rophages per animal. Data are presented as mean 6 SEM for five mice.1546 Gene Targeting of T1/ST2
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